4
Changes in Ownership
NovoCure Ltd Filed Acc 0001645113-21-000109
Chief Development Officer sold 540 shares at $138.23 ($74,645)
From the SEC's structured data for this filing
Trades in this filing
Leonard Frank X · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-02 | Sale : show line 1 in the form | −540 | $138.23 | $74,645 | 87,153 | D |
| Open-market sales · 540 sh · avg $138.23 · $74,645 | ||||||
Loading xslF345X03/wf-form4_163104715467852.xml…